Lupin launches fixed dose triple combo inhaler for COPD in India

The product is an important addition to Lupin’s respiratory portfolio.

Related stories

business

Individuals spared from new FEMA reporting requirement: RBI clarifies

business

RBI to allow inter-operability among account aggregators; integrate bank deposits with CAS

business

CDK Global appoints Sudhakar Ramakrishna CEO

business

GST Council meets tomorrow, tax experts say reforms must move beyond rates to processes, compliance